Nicklas Westerholm

Vorstandsvorsitzender bei EGETIS THERAPEUTICS AB

Vermögen: 114 876 $ am 30.04.2024

48 Jahre

Health Technology

Consumer Services

Commercial Services

Aktive Positionen von Nicklas Westerholm

Unternehmen	Position	Beginn	Ende
EGETIS THERAPEUTICS AB	Vorstandsvorsitzender	16.06.2017	-
	Investor Relations Kontakt	16.06.2017	01.02.2022
	Public Communications Contact	16.06.2017	01.02.2022
SPAGO NANOMEDICAL AB	Direktor/Vorstandsmitglied	08.05.2019	-
SPAGO NANOMEDICAL AB	Independent Dir/Board Member	08.05.2019	-
Rare Thyroid Therapeutics International AB Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden.	Vorstandsvorsitzender	-	-
	Vorsitzender	-	-

Unternehmen	Position	Beginn	Ende
AstraZeneca AB AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.	Corporate Officer/Principal	01.01.1995	01.06.2017
ASTRAZENECA PLC	Investor Relations Kontakt	11.04.2011	08.09.2011
ASTRAZENECA PLC	Public Communications Contact	03.03.2011	-

Royal Institute of Technology	Undergraduate Degree
University of Stockholm	Undergraduate Degree

International

Schweden	7
Vereinigtes Königreich	2

Operativ

Investor Relations Contact	2
Public Communications Contact	2
Chief Executive Officer	2

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
ASTRAZENECA PLC	Health Technology
EGETIS THERAPEUTICS AB	Health Technology
SPAGO NANOMEDICAL AB	Health Technology

Private Unternehmen	2
AstraZeneca AB AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.	Commercial Services
Rare Thyroid Therapeutics International AB Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden.	Health Technology

Private Unternehmen

Commercial Services

Health Technology